Lars Buschhorn
Impact in
-
- Cancer Genomics and Diagnostics
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- Cancer Genomics and Diagnostics 6
- Oncology 4
- Colorectal Cancer Treatments and Studies 2
- Co-authors
- Adam Wahida (7 shared papers)Andreas Schneeweiß (5 shared papers)Philipp J. Jost (3 shared papers)Peter Lichter (1 shared paper)Vivek Subbiah (6 shared papers)Stefan Fröhling (1 shared paper)Razelle Kurzrock (2 shared papers)Mohamed A. Gouda (5 shared papers)
- Journals
- Nature Medicine (1 paper)ESMO Open (1 paper)Clinical Cancer Research (1 paper)Breast Care (1 paper)Nature reviews. Cancer (1 paper)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Lars Buschhorn
9 papers receiving 291 citations
Peers
Comparison fields: 5 of 55
- Cancer Research 110
- Oncology 85
- Hematology 26
- Pulmonary and Respiratory Medicine 66
- Genetics 18
Countries citing papers authored by Lars Buschhorn
This map shows the geographic impact of Lars Buschhorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Buschhorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Buschhorn more than expected).
Fields of papers citing papers by Lars Buschhorn
This network shows the impact of papers produced by Lars Buschhorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Buschhorn. The network helps show where Lars Buschhorn may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Buschhorn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 130 | |
| 2 | 2023 | 54 | |
| 3 | 2023 | 40 | |
| 4 | 2019 | 32 | |
| 5 | 2023 | 28 | |
| 6 | 2025 | 6 | |
| 7 | 2021 | 3 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 0 | |
| 11 | 2023 | 0 |
About Lars Buschhorn
Lars Buschhorn is a scholar working on Cancer Research, Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Genetics, having authored 11 papers that have together received 295 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (6 papers), Radiomics and Machine Learning in Medical Imaging (4 papers), Colorectal Cancer Treatments and Studies (2 papers), Acute Myeloid Leukemia Research (1 paper), Chronic Myeloid Leukemia Treatments (1 paper), Mathematical Biology Tumor Growth (1 paper), Melanoma and MAPK Pathways (1 paper) and Histone Deacetylase Inhibitors Research (1 paper). The work is most often cited by research in Cancer Research (110 citations), Oncology (85 citations), Hematology (26 citations), Pulmonary and Respiratory Medicine (66 citations) and Genetics (18 citations). Lars Buschhorn has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Adam Wahida, Andreas Schneeweiß, Philipp J. Jost, Peter Lichter, Vivek Subbiah, Stefan Fröhling, Razelle Kurzrock, Mohamed A. Gouda, Blessie Elizabeth Nelson and Alessandro Russo. Their work appears in journals such as Nature Medicine, ESMO Open, Clinical Cancer Research, Breast Care and Nature reviews. Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.